By Dr. Moxit Shah, Endocrinologist, Ahmedabad
What is Yurpeak?
Yurpeak is a once-weekly injectable medication containing tirzepatide, one of the most effective modern treatments for both obesity and type 2 diabetes. It is marketed in India by Cipla under an agreement with Eli Lilly and is available in a convenient KwikPen device.
Tirzepatide has gained worldwide attention because it targets two important metabolic hormones—GIP and GLP-1—making it highly effective for blood sugar control and weight reduction.
How Does Yurpeak Work?
Yurpeak works by:
- Increasing insulin secretion when blood sugar rises
- Reducing glucagon production
- Slowing stomach emptying
- Reducing hunger and food cravings
- Increasing the feeling of fullness after meals
These actions help patients achieve better diabetes control while simultaneously losing excess weight.
Who Can Benefit from Yurpeak?
Patients with Type 2 Diabetes
Yurpeak helps lower:
- Fasting blood sugar
- Post-meal blood sugar
- HbA1c levels
Many patients experience significant improvements in diabetes control with fewer fluctuations in blood glucose levels.
Patients Struggling with Weight Loss
Yurpeak is also approved for chronic weight management in adults with:
- BMI ≥ 30 kg/m² (Obesity)
- BMI ≥ 27 kg/m² with conditions such as diabetes, hypertension, fatty liver, or sleep apnea
When combined with proper nutrition and exercise, patients often achieve substantial and sustained weight loss.
What Are the Available Doses?
Yurpeak KwikPen is available in:
- 2.5 mg
- 5 mg
- 7.5 mg
- 10 mg
- 12.5 mg
- 15 mg
Treatment typically starts at 2.5 mg once weekly and is gradually increased depending on response and tolerance.
What Are the Common Side Effects?
Most side effects are mild and temporary:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Indigestion
- Reduced appetite
These symptoms usually improve as the body adjusts to treatment.
Who Should Not Take Yurpeak?
Yurpeak may not be suitable for everyone. A detailed evaluation by an endocrinologist is essential before starting therapy.
Special caution is required in patients with:
- Previous pancreatitis
- Severe gastrointestinal disease
- Pregnancy
- Breastfeeding
- Certain endocrine conditions
Never start Yurpeak without medical supervision.
Yurpeak vs Mounjaro: What’s the Difference?
Many patients ask whether Yurpeak and Mounjaro are different.
The answer is simple:
Both contain the same active ingredient, tirzepatide. The primary difference lies in branding and distribution. Eli Lilly manufactures tirzepatide, while Cipla distributes Yurpeak in India.
Is Yurpeak Better Than Ozempic?
Yurpeak (tirzepatide) acts on both GIP and GLP-1 receptors, whereas semaglutide (Ozempic) acts only on GLP-1 receptors.
Clinical studies have shown that tirzepatide often produces:
- Greater HbA1c reduction
- Greater weight loss
- Better metabolic outcomes
However, the best medication varies from patient to patient and should be selected by a qualified endocrinologist.
Expert Opinion from Dr. Moxit Shah
Obesity and diabetes are chronic medical conditions that require long-term management. Yurpeak represents one of the most significant advances in metabolic medicine in recent years.
The key to success is not just the injection itself but a comprehensive treatment plan that includes:
- Personalized nutrition
- Physical activity
- Sleep optimization
- Regular monitoring
- Medical supervision
If you are struggling with obesity, diabetes, insulin resistance, PCOS, or fatty liver disease, an expert endocrine evaluation can help determine whether Yurpeak is the right treatment option for you.
Consult Dr. Moxit Shah
Endocrinologist, Diabetes,Thyroid & Weight Loss Specialist
📍 Ahmedabad, Gujarat
📞 9979992797
🌐 www.endocrinologistinahmedabad.com
